.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Delhi government recently announced a significant Ayushman Bharat Delhi expansion to enhance healthcare access for vulnerable populations. This policy change specifically targets widows and persons with disabilities. Consequently, these individuals can now access comprehensive health insurance without financial worry. Chief Minister Rekha Gupta emphasized that this move ensures no citizen is deprived of quality treatment due to poverty.
The Delhi Cabinet decided to include approximately 3.97 lakh widows in the Pradhan Mantri Jan Arogya Yojana (PMJAY). Furthermore, 1.31 lakh Divyang or disabled persons will join the scheme. This decision extends benefits to their entire families as well. As a result, about 5.5 lakh additional families will receive robust health security cover. This group adds to the 5.5 lakh families already receiving benefits in the capital. The initiative focuses on making healthcare more inclusive and effective for all needy citizens.
The government is working hard to implement these changes effectively across the city. Currently, the state has issued 7,23,707 Ayushman cards to eligible residents. This total includes over 2.7 lakh cards for senior citizens above 70 years. To provide care, a network of 208 hospitals is already empanelled in Delhi. This network consists of 156 private hospitals and 53 government facilities. Therefore, patients have diverse options for seeking specialized medical services. To date, more than 29,120 beneficiaries have already received treatment through the State Health Agency.
Q1: Who are the new beneficiaries included in the Delhi PMJAY scheme?
The scheme now includes approximately 3.97 lakh widows and 1.31 lakh persons with disabilities (Divyang), along with their families.
Q2: How many hospitals in Delhi are empanelled under the Ayushman Bharat scheme?
There are currently 208 hospitals empanelled, comprising 156 private hospitals and 53 government hospitals.
Q3: Does the scheme cover senior citizens in Delhi?
Yes, senior citizens above 70 years of age are already covered under the scheme, with over 2.74 lakh cards issued to them so far.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Delhi government has included 3.97 lakh widows and 1.31 lakh disabled persons under the Ayushman Bharat PMJAY scheme, adding 5.5 lakh families to the co...
6 months ago
A nationwide study reveals stable pathogen specification rates in infectious diarrhea hospitalizations from 2016 to 2023, accompanied by a marked decline in Clostridioides difficile cases, emphasizing the need for targeted diagnostic stewardship and thoughtful multiplex testing in hospital medicine.
3 days back
A real-world cohort study evaluates anti-Müllerian hormone recovery and fertility outcomes in high-risk GTN patients treated with EMA/CO versus FAEV chemotherapy, demonstrating robust ovarian reserve recovery by six months post-treatment.
4 days back
A real-world Japanese claims database analysis reveals that the 2021 heart failure guideline update drove significant improvements in guideline-directed medical therapy (GDMT). The study highlighted substantial increases in the prescription of sacubitril/valsartan and dapagliflozin among heart failure patients.
4 days back
A multicenter prospective cohort study reveals that 54.1% of patients achieve clinically meaningful neuropathic pain relief after surgery for degenerative cervical myelopathy, driving substantial gains in motor function, mental health, and quality of life.
3 days back
The ferroptosis-immunity axis represents a critical driver of diabetic kidney disease progression. This review explores iron-dependent lipid peroxidation, innate immune cross-talk, emerging candidate biomarkers, and promising targeted therapies to delay renal decline alongside standard glycemic control.
4 days back
